Impact Journals Spotlight
Latest Posts
Aging
ONCOTARGET
Behind the Study: HER3: A Vital Target in Cancer Treatment
Dr. Omkar Desai, from the Department of Surgery at Case Western Reserve University and University Hospitals Cleveland Medical Center, describes a research perspective he co-authored with Dr. Rui Wang that was published by Oncotarget in Volume 14, entitled, “HER3- A…
Behind the Study: ER Expression Multiclonality in DCIS: Clinical & Future Insights
Dr. Mangesh A. Thorat from Guy’s Hospital in London, Queen Mary University of London, and King’s College London, describes a recent editorial he authored that was published by Oncotarget in Volume 14, entitled, “Multiclonality of ER expression in DCIS – Implications…
Behind the Study: Molecular Dialogue Between Tumor Cells and Fibroblasts
Dr. Gopal C. Kundu from KIIT Deemed to be University in Odisha, India, describes a recent editorial he co-authored that was published by Oncotarget in Volume 14, entitled, “The molecular dialogue between the tumor cells and fibroblasts.” Listen to an…
VIEW MORE ONCOTARGET ARTICLES ➜
ONCOSCIENCE
Behind the Study: Global Pandemic Exit Strategy: Equity and Immunity
Dr. Lennard YW Lee, Yuxin Ying and Jola Bytyci from the University of Oxford, UK, elaborate on a recent editorial they co-authored that was published by Oncoscience in Volume 10, entitled, “Exiting the pandemic together: achieving global immunity and equity.”…
Behind the Study: Leveraging Scientific Findings to Develop Therapeutic Strategies for Dormant Breast Cancer Cells
Alejandra Ferrer, PhD candidate in the Department of Medicine-Hematology/Oncology at Rutgers New Jersey Medical School, elaborates on a recent research perspective she co-authored that was published by Oncoscience, entitled, “Leveraging the scientific findings to develop therapeutic strategies for dormant breast…
VIEW MORE ONCOSCIENCE ARTICLES ➜
GENES & CANCER
Behind the Study: Reaching Beyond Family History as Inclusion Criteria for Pancreatic Cancer Surveillance in High-risk Populations
Dr. Louise Wang from Yale School of Medicine and the VA Connecticut Healthcare system, describes a recent editorial she co-authored that was published by Genes & Cancer, entitled, “Reaching beyond family history as inclusion criteria for pancreatic cancer surveillance in…
VIEW MORE GENES & CANCER ARTICLES ➜
VIEW MORE SPOTLIGHT ARTICLES ➜